RMTI Rockwell Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RMTI

Price (delayed)

$8.55

Market cap

$34.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.34

Enterprise value

$37.87M

?
Relative Growth: Rel. Growth: 12
Relative Strength: Rel. Strength: 52
Relative Valuation: Rel. Valuation: 34
Relative Profitability: Rel. Profitability: 13

Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics ...

Highlights
RMTI's gross margin is up by 3.5% QoQ
The company's debt fell by 3.2% QoQ
The net income has shrunk by 142% YoY but it has increased by 6% QoQ
The EPS has plunged by 72% YoY but it has grown by 9% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.rockwellmed.com
Peers: ICUI BAX ABT NEPH

Key stats

What are the main financial stats of RMTI

RMTI stock price

How has the Rockwell Medical stock price performed over time
Intraday
-0.23%
1 week
8.09%
1 month
8.23%
1 year
-32.14%
YTD
2.52%
QTD
55.17%

Financial performance

How have Rockwell Medical's revenue and profit performed over time
Revenue
$69.39M
Gross profit
$12.29M
Operating income
-$4.52M
Net income
-$5.08M
Gross margin
17.7%
Net margin
-7.3%
The net income has shrunk by 142% YoY but it has increased by 6% QoQ
Rockwell Medical's revenue has decreased by 21% YoY but it has increased by 2.5% from the previous quarter
The gross profit fell by 20% YoY but it rose by 6% QoQ
The company's net margin rose by 9% QoQ

Price vs fundamentals

How does RMTI's price correlate with its fundamentals

Growth

What is Rockwell Medical's growth rate over time

Valuation

What is Rockwell Medical stock price valuation
P/E
N/A
P/B
0.96
P/S
0.49
EV/EBIT
N/A
EV/EBITDA
216.43
EV/Sales
0.55
The EPS has plunged by 72% YoY but it has grown by 9% from the previous quarter
RMTI's price to book (P/B) is 66% lower than its 5-year quarterly average of 2.8 but 7% higher than its last 4 quarters average of 0.9
RMTI's equity is up by 15% year-on-year but it is down by 2.2% since the previous quarter
Rockwell Medical's revenue has decreased by 21% YoY but it has increased by 2.5% from the previous quarter
RMTI's price to sales (P/S) is 18% lower than its 5-year quarterly average of 0.6 and 2% lower than its last 4 quarters average of 0.5

Efficiency

How efficient is Rockwell Medical business performance
Rockwell Medical's return on assets has shrunk by 134% YoY but it has increased by 7% QoQ
RMTI's return on equity has dropped by 106% year-on-year but it is up by 9% since the previous quarter
The return on invested capital has increased by 11% since the previous quarter
The ROS has grown by 10% from the previous quarter

Dividends

What is RMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RMTI.

Financial health

How did Rockwell Medical financials performed over time
Rockwell Medical's total assets is 164% more than its total liabilities
RMTI's quick ratio is up by 22% YoY but it is down by 11% QoQ
RMTI's current ratio is down by 13% QoQ but it is up by 12% YoY
The company's debt is 60% lower than its equity
RMTI's equity is up by 15% year-on-year but it is down by 2.2% since the previous quarter
The debt to equity has contracted by 13% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.